Pharmacy practice research priorities during the COVID-19 pandemic : Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group
Copyright © 2020 Elsevier Inc. All rights reserved..
Across the globe, pharmacists on the frontline continue to fight COVID-19 and its continuously evolving physical, mental, and economic consequences armed by their knowledge, professionalism, and dedication. Their need for credible scientific evidence to inform their practice has never been more urgent. Despite the exponentially increasing number of publications since the start of the pandemic, questions remain unanswered, and more are created, than have been resolved by the increasing number of publications. A panel of leading journal editors was convened by the International Pharmaceutical Federation (FIP) Pharmacy Practice Research Special Interest Group to discuss the current status of COVID-19 related research, provide their recommendations, and identify focal points for pharmacy practice, social pharmacy, and education research moving forward. Key priorities identified spanned a wide range of topics, reflecting the need for good quality research to inform practice and education. The panel insisted that a foundation in theory and use of rigorous methods should continue forming the basis of inquiry and its resultant papers, regardless of topic area. From assessing the clinical and cost effectiveness of COVID-19 therapies and vaccines to assessing different models of pharmaceutical services and education delivery, these priorities will ensure that our practice is informed by the best quality scientific evidence at this very challenging time.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
Research in social & administrative pharmacy : RSAP - 17(2021), 1 vom: 10. Jan., Seite 1903-1907 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dawoud, Dalia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 22.12.2020 Date Revised 29.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.sapharm.2020.08.020 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314850279 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314850279 | ||
| 003 | DE-627 | ||
| 005 | 20240329235007.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.sapharm.2020.08.020 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1354.xml |
| 035 | |a (DE-627)NLM314850279 | ||
| 035 | |a (NLM)32912829 | ||
| 035 | |a (PII)S1551-7411(20)31044-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dawoud, Dalia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacy practice research priorities during the COVID-19 pandemic |b Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.12.2020 | ||
| 500 | |a Date Revised 29.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
| 520 | |a Across the globe, pharmacists on the frontline continue to fight COVID-19 and its continuously evolving physical, mental, and economic consequences armed by their knowledge, professionalism, and dedication. Their need for credible scientific evidence to inform their practice has never been more urgent. Despite the exponentially increasing number of publications since the start of the pandemic, questions remain unanswered, and more are created, than have been resolved by the increasing number of publications. A panel of leading journal editors was convened by the International Pharmaceutical Federation (FIP) Pharmacy Practice Research Special Interest Group to discuss the current status of COVID-19 related research, provide their recommendations, and identify focal points for pharmacy practice, social pharmacy, and education research moving forward. Key priorities identified spanned a wide range of topics, reflecting the need for good quality research to inform practice and education. The panel insisted that a foundation in theory and use of rigorous methods should continue forming the basis of inquiry and its resultant papers, regardless of topic area. From assessing the clinical and cost effectiveness of COVID-19 therapies and vaccines to assessing different models of pharmaceutical services and education delivery, these priorities will ensure that our practice is informed by the best quality scientific evidence at this very challenging time | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Pharmacy education | |
| 650 | 4 | |a Pharmacy practice | |
| 650 | 4 | |a Research | |
| 700 | 1 | |a Chen, Aleda M H |e verfasserin |4 aut | |
| 700 | 1 | |a Rossing, Charlotte Verner |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia-Cardenas, Victoria |e verfasserin |4 aut | |
| 700 | 1 | |a Law, Anandi V |e verfasserin |4 aut | |
| 700 | 1 | |a Aslani, Parisa |e verfasserin |4 aut | |
| 700 | 1 | |a Bates, Ian |e verfasserin |4 aut | |
| 700 | 1 | |a Babar, Zaheer-Ud-Din |e verfasserin |4 aut | |
| 700 | 1 | |a Desselle, Shane |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Research in social & administrative pharmacy : RSAP |d 2005 |g 17(2021), 1 vom: 10. Jan., Seite 1903-1907 |w (DE-627)NLM166902047 |x 1934-8150 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2021 |g number:1 |g day:10 |g month:01 |g pages:1903-1907 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.sapharm.2020.08.020 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2021 |e 1 |b 10 |c 01 |h 1903-1907 | ||